JPRN-UMIN000015323已完成未知
The changes of renin, angiotensin and aldosterone with long term administration of olmesartan:COMPATIBLE extension study - COMPATIBLE extension RAS study
Kanagawa Association of Medical and Dental Practitioners0 个研究点目标入组 100 人开始时间: 2014年10月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patient who do not take Olmesartan.
研究者
相似试验
招募中
不适用
Impact of Renin-Angiotensin-Aldosterone-System Inhibition on Advanced Chronic Kidney Disease progression – a Retrospective Observational StudyN18.4Chronic kidney disease, stage 4DRKS00034706niversitätsklinikum Freiburg6,000
Unknown
不适用
Effect of RAAS Blockade on Renal Outcome in CKD Stage 3-4 with Type 2 DM Patients: A Retrospective cohort studychronic kidney disease stage 3-4 type 2 diabetes mellitusdiabetes mellituschronic kidney diseaseTCTR20230512002Faculty of Pharmaceutical Sciences, Burapha University13,488
撤回
不适用
Renin-Angiotensin System and Other Markers in Strawberry Birthmarks in infants and young children with growing problematic haemangiomasInfantile HaemangiomaSkin - Dermatological conditionsACTRN12612001227886Hutt Valley DHB40
已完成
2 期
Irbesartan and Atenolol in Hypertensive Heart DiseaseHypertensionNCT00389168Karolinska Institutet115
进行中（未招募）
1 期
BLOCKADE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN PATIENTS WITH ARVD.BRAVEArrhythmogenic right ventricular dysplasiaMedDRA version: 20.1Level: PTClassification code: 10058093Term: Arrhythmogenic right ventricular dysplasia Class: 100000004850CTIS2023-505048-20-00Hospices Civils De Lyon120